Antibodies against 9-O-acetylated sialoglycans: A potent marker to monitor clinical status in childhood acute lymphoblastic leukemia

Clinical Biochemistry

Volumn 37, Issue 5, 2004, Pages 395-403

  Pal, Santanu ^a   Bandyopadhyay, Suman ^a   Chatterjee, Mitali ^b   Bhattacharya, Dilip K ^c   Minto, Lynne ^d   Hall, Andrew G ^d   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b IPGMER   (India)

^c VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Achatinin H; Acute lymphoblastic leukemia (ALL); Antibodies against 9 O acetylated sialic acids; Bovine submaxillary mucin; O acetylated sialic acids

Indexed keywords

ANTIBODY; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN G; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; SIALOGLYCAN ANTIBODY; TIOGUANINE; UNCLASSIFIED DRUG; VINCRISTINE;

ACETYLATION; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIBODY TITER; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYMPHOBLAST; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; REMISSION; SAMPLE SIZE;

ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOGLOBULIN G; INDIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; POLYSACCHARIDES; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ANTIGEN, B-CELL; SENSITIVITY AND SPECIFICITY; SIALIC ACIDS; TUMOR MARKERS, BIOLOGICAL;

EID: 1842861772     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.01.001     Document Type: Article

References (33)

1. Pui C.H., Campana D., Evans W.E. Childhood acute lymphoblastic leukemia - Current status and future perspectives. Lancet Oncol. 2:2001;597-607.
2. Marshall G.M., Haber M., Kwan E.et al. Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. J. Clin. Oncol. 15:2003;704-709.
3. Mandal C., Chatterjee M., Sinha D. Investigation of 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukemia. Br. J. Haematol. 110:2000;801-812.
4. Kelm S., Schauer R. Sialic acids in molecular and cellular interactions. Int. Rev. Cytol. 175:1997;137-240.
5. Klein A., Roussel P. O-Acetylation of sialic acids. Biochimie. 80:1998;49-57.
6. Angata T., Varki A. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem. Rev. 102:2002;439-469.
7. Zeng F.Y., Wegenka U., Gabius H.J. Purification and properties of a fucoidan binding protein from human placenta and its identification as immunoglobulin G. Int. J. Biochem. 24:1992;1329-1340.
8. H, as a probe. Leukemia. 13:1999;119-125.
9. Sinha D., Mandal C., Bhattacharya D.K. A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukemia. 13:1999;309-312.
10. Sinha D., Chatterjee M., Mandal C. O-Acetylated sialic acids - Their detection, biological significance and alteration in diseases. Trends Glycosci. Glycotechnol. 12:2000;17-33.
11. Pal S., Chatterjee M., Bhattacharya D.K., Bandhyopadhyay S., Mandal C. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia. Glycobiology. 10:2000;539-549.
12. Pal S., Chatterjee M., Bhattacharya D.K., Bandhyopadhyay S., Mandal C., Mandal C. O-Acetyl sialic acid specific IgM as a diagnostic marker in childhood acute lymphoblastic leukemia. Glycoconj. J. 18:2001;529-537.
13. Burns P., Armitage J.O., Frey A.L., Dick F.R., Jordan J.E., Woolson R.F. Analysis of the presenting features of adult acute leukemias: the French-American-British classification. Cancer. 47:1981;2460-2469.
14. Eden O.B., Harrison G., Richards S.et al. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukemia, 1980-1997. Leukemia. 14:2000;2307-2320.
15. Murphy W.H., Gottschalk A. Studies on mucoproteins; the linkage of the prosthetic group to aspartic and glutamic acid residues in bovine submaxillary gland mucoprotein. Biochim. Biophys. Acta. 52:1961;349-360.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Sharma V., Chatterjee M., Sen G., Chava A.K., Mandal C. Role of linkage specific 9-O-acetylated Sialoglycoconjugates in activation of the alternate complement pathway in mammalian erythrocytes. Glycoconj. J. 17:2000;887-893.
18. Chatterjee M., Chava A.K., Kohla G.et al. Identification and characterization of adsorbed serum sialoglycans on Leishmania donovani promastigotes. Glycobiology. 13:2003;351-361.
19. Reuter G., Pfeil R., Stoll S.et al. Identification of new sialic acids derived from glycoprotein of bovine submandibular gland. Eur. J. Biochem. 134:1983;139-143.
20. Kohn J., Wilchek M. A new approach (Cyano-transfer) for cyanogen bromide activation of sepharose at neutral pH, which yields activated resin, free of interfering nitrogen derivatives. Biochem. Biophys. Res. Commun. 107:1982;878-884.
21. GD1a and NMR-based analysis of its binding to a human polyclonal immunoglobulin G fraction with selectivity for O-acetylated sialic acids. Glycobiology. 6:1996;561-572.
22. D'Allesandro M., Mariani P., Lomanto D., Bachetoni A., Speranza V. Alterations in serum anti-α-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis. Clin. Immunol. 103:2002;63-68.
23. Varki A. Diversity in the sialic acids. Glycobiology. 2:1992;25-40.
24. Anderhuber W., Steinschifter W., Schauenstein E.et al. The IgG1/G2 subclass shift - A sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck. Br. J. Cancer. 79:1999;1777-1781.
25. Blaes F., Klotz M., Funke D., Strittmatter M., Kraus J., Kaps M. Disturbance in the serum IgG subclass distribution in patients with anti-Hu positive paraneoplastic neurological syndromes. Eur. J. Neurol. 9:2002;369-372.
26. Kluin-Nelemans H.C., Krouwels M.M., Jansen J.H.et al. Hairy cell leukemia preferentially expresses the IgG3-subclass. Blood. 75:1990;972-975.
27. Klotz M., Blaes F., Funke D., Kalweit G., Schimrigk K., Huwer H. Shift in the IgG subclass distribution in patients with lung cancer. Lung Cancer. 24:1999;25-30.
28. 2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engl. J. Med. 303:1980;178-182.
29. Felsner P., Steinschifter W., Fischer M.et al. The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignancies. Cancer. 88:2000;461-467.
30. Pui C.H. Childhood leukemias. N. Engl. J. Med. 332:1995;1618-1630.
31. Coustan-Smith E., Behm F.G., Sanchez J.et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet. 351:1998;550-554.
32. Sinha D., Mandal C., Bhattacharya D.K. Development of a simple, blood based lymphoproliferation assay to assess the clinical status of patients acute lymphoblastic leukemia. Leuk. Res. 23:1999;433-439.
33. H: a 9-O acetyl sialic acid binding lectin. Leuk. Res. 23:1999;803-809.